Ranbaxy stock extends loss over FDA concerns

Extending Monday's steep fall, shares of Ranbaxy Laboratories on Tuesday fell over 2 per cent after the USFDA raised concerns about manufacturing practices at the pharmaceutical firm's Toansa plant in Punjab.









from Business Today| MARKETS http://businesstoday.feedsportal.com/c/33681/f/593059/s/35e025b6/sc/1/l/0Lbusinesstoday0Bintoday0Bin0Cstory0Cranbaxy0Estock0Eextends0Eloss0Eover0Efda0Econcerns0C10C20A23450Bhtml/story01.htm